• Unique, battle-tested and patented AI image analysis technology ready for commercialization in U.S. defense and public safety markets following more than two years of real-world usage in Ukraine.
• Well positioned to capitalize on U.S. military’s increased strategic focus on domestically produced drone and AI technologies through integration with currently deployed platforms such as the U.S. Army’s Tactical Assault Kit (“TAK”) ecosystem for military force protection.
• The patented SpotlightAI(TM) platform enables real-time detection of over 150 types of mines and UXO using AI and drone imagery and is now operating at scale, creating the world’s largest datasets of real-world landmines and UXO built on more than 1.6 million battlefield images processed and 28,000 threats identified.
• Safe Pro is addressing a global, multi-billion-dollar need for scalable defense, public safety and demining solutions.

Safe Pro Group (NASDAQ: SPAI) is a mission-driven technology company delivering advanced AI-powered security and defense solutions. It is focused on serving customers in the defense, homeland security, humanitarian, law enforcement, and commercial markets where its AI, drone-based services and ballistic protective gear can synergistically deliver safety and operational efficiency.

At the heart of Safe Pro’s mission is its patented artificial intelligence (“AI”), machine learning (“ML”), deep learning and applied computer vision software technology. These tools are currently being used to rapidly detect small objects in drone-based video and imagery such as landmines and unexploded ordnance (“UXO”), enabling safer and more efficient field operations across global conflict and post-conflict zones and supporting efforts to improve the reliability of critical infrastructure. The company’s vision is to lead the evolution of security and threat detection through AI innovation, while its mission is to empower governments, enterprises, and humanitarian organizations with tools to respond to evolving threats at scale.

With a team of leaders and subject matter experts drawn from the defense, technology, and public safety sectors, Safe Pro Group delivers U.S.-developed next-generation AI and drone services through its Safe Pro AI and Airborne Response units and high-performance, American-made ballistic protective solutions through its Safe-Pro USA subsidiary.

The company is headquartered in Aventura, Florida.

Products

Safe Pro Group’s three business units operate across software, hardware, and field services to deliver a comprehensive suite of solutions. Each division plays a distinct role in supporting defense, humanitarian and public safety missions around the world.

Safe Pro AI

Safe Pro AI’s core AI-powered computer vision technology enables the rapid analysis of drone-based imagery to autonomously detect objects of interest. Its flagship product, SpotlightAI(TM) can detect and label over 150 types of explosive threats including landmines, cluster munitions, and unexploded ordnance (“UXO”). Built on more than two years of real-world usage in Ukraine and now including additional imagery being gathered from the Asian-Pacific region and Africa, SpotlightAI(TM) rapidly processes and creates high-resolution maps supported by the hyper scalability of the Amazon Web Services (“AWS”) cloud or detects threats in real-time locally through its OnSite Windows-based software application. Today, the platform boasts one of the world’s largest datasets built on over 1.6 million real-world battlefield images from Ukraine, identifying 28,000+ threats across more than 6,750 hectares, an area equivalent in size to Manhattan.

Airborne Response

Airborne Response is a leading provider of mission critical drone services using U.S. Government-compliant small uncrewed aircraft systems (“sUAS”) (drones). It serves enterprises in utilities and telecom and insurance with a full-range of drone-based critical infrastructure inspection and monitoring solutions as well as Drone-as-a-First Responder (“DFR”) services for law enforcement and public safety. It provides customers with actionable intelligence though data capture, analytics and processing powered by AI.

Safe-Pro USA

Safe-Pro USA manufactures ultra-premium, American-made ballistic protection systems including advanced body armor and ballistic plates as well as complete Explosive Ordnance Disposal (“EOD”) suits, demining aprons, and bomb blankets. All products exceed U.S. and NATO standards and are designed, engineered, and produced in the U.S., supporting customers across military, humanitarian, and law enforcement sectors.

Market Opportunity

Harnessing its patented, real-time, AI-powered processing of drone-based imagery, Safe Pro is creating a uniquely powerful ‘Next-Gen’ approach to situational awareness supporting ground-based personnel in safely completing their defense/military, humanitarian, law enforcement & commercial missions.

The global threat posed by landmines and UXO spans nearly 60 countries, affecting millions of civilians and imposing significant economic burdens, particularly in agriculture and infrastructure. In Ukraine alone, the contamination of 17 million hectares has resulted in $50+ billion in agricultural losses, with World Bank estimates projecting $30 billion needed in demining costs. According to the Landmine Monitor 2024, regions in Asia, Africa, and Latin America continue to report high casualty rates.

Safe Pro is positioned to capture a portion of the $15 billion+ global defense tech market, especially in AI-driven battlefield intelligence, drone surveillance, and threat detection. As a U.S.-based AI and defense technology provider with a HUBZone-certified manufacturing arm, Safe Pro is eligible for federal and state procurement programs, public safety grants, and critical infrastructure contracts, as well as global humanitarian demining efforts.

Leadership Team

Dan Erdberg, Chairman and CEO, brings over 20 years of experience as a C-level technology executive. He has led multiple Nasdaq listings in the drone, 5G, and satellite communications sectors, raised over $50 million in growth capital, and spearheaded Safe Pro Group’s corporate strategy and acquisitions.

Theresa Carlise, Chief Financial Officer, has more than 30 years of experience in financial leadership roles for public companies. Her expertise includes equity transactions, strategic planning, and financial restructuring. She served as Chief Financial Officer, Secretary, Treasurer and Director of various publicly traded companies within the retail, telecommunications, distribution, transportation, mortgage banking and construction sectors.

Pravin Borkar, CTO and Director (President, Safe-Pro USA), has over 30 years of experience in the engineering and manufacturing of ballistic protection systems for the U.S. Department of Defense. He has developed armor solutions for personnel and aircraft platforms including the CH-53 and Blackhawk.

Christopher Todd, President (Airborne Response), is a drone industry veteran and Certified Emergency Manager (CEM(R)) with more than 30 years of experience. He founded Airborne Response and is President of AUVSI Florida, with expertise in public safety drone deployment and emergency response.

For more information, visit the company’s website at https://safeprogroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SPAI are available in the company’s newsroom at https://ibn.fm/SPAI

• Safe Pro leverages patented AI and drone-based imagery analysis for threat detection and demining efforts.
• Membership in the index reflects the company’s growing market presence and performance in AI-powered security and defense solutions, boosting visibility among institutional investors and fund managers.
• The company’s flagship SpotlightAI(TM) platform has analyzed over 1.6 million real-world battlefield images from Ukraine, identifying more than 28,000 explosive threats.
• Safe Pro is targeting a share of the global $15 billion defense technology market through its U.S.-made and HUBZone-certified offerings.

Safe Pro Group (NASDAQ: SPAI), an emerging provider of AI-powered security and threat detection solutions, announced its addition to the Russell Microcap(R) Index, effective after market close on June 27, 2025. The inclusion comes as part of FTSE Russell’s annual reconstitution, which ranks companies based on objective measures of market capitalization and style factors (https://ibn.fm/Bjka9).

For Safe Pro, joining the Russell Microcap(R) Index marks a new phase of investor awareness, offering automatic inclusion in funds and indexes tracked by institutional investors and fund managers. The inclusion further highlights the company’s growing market presence and performance and provides overall increased visibility within the investor community.

Founded to address global security, defense, and humanitarian challenges, Safe Pro has built a portfolio combining artificial intelligence, machine learning, and drone-based technologies. Its flagship SpotlightAI(TM) software platform supports real-time detection of over 150 types of mines and unexploded ordnance (“UXO”), built on a dataset of more than 1.6 million battlefield images from conflict zones such as Ukraine. The technology has identified over 28,000 threats so far, demonstrating practical results in one of the world’s most mine-contaminated regions.

The company’s growth is aligned with a larger industry trend, as defense and humanitarian organizations increasingly demand scalable, AI-enabled systems. SpotlightAI(TM) works by analyzing imagery from commercial, off-the-shelf drones, providing a rapid, efficient alternative to traditional human-based threat identification. Safe Pro’s cloud-based ecosystem, built on Amazon Web Services (“AWS”), supports high-volume data processing as well as enabling local real-time analysis through its OnSite software.

Beyond software, Safe Pro operates the Airborne Response division, which delivers mission-critical drone services for industries such as telecom, utilities, insurance, and public safety. Airborne Response specializes in drone-as-a-first-responder programs and infrastructure inspections, supporting operations with AI-enhanced data analysis.

In addition, Safe-Pro USA, another division, produces advanced, high performance ballistic protective systems, including body armor and plates for law enforcement as well as explosive ordnance disposal (“EOD”) suits and bomb blankets, all designed to meet or exceed NATO and U.S. military standards. Because all of its protective solutions are made in the United States and it is a HUBZone-certified small business, Safe-Pro USA is eligible for U.S. government procurement programs and public safety grants, positioning the company to expand its footprint across federal, state, and international markets.

The global landmine and UXO threat continues to affect nearly 60 countries, imposing social and economic burdens from agriculture to critical infrastructure. According to World Bank estimates, Ukraine alone faces roughly $30 billion in demining costs following contamination of more than 17 million hectares of land. As the “Breadbasket of Europe,” Ukraine’s agricultural sector has suffered more than $50 billion in losses since the beginning of the large-scale invasion (Source: All-Ukrainian Agrarian Council, July 2024). 

Through its portfolio of unique technologies, solutions and products, Safe Pro is well-placed to capture a portion of the estimated $15 billion global defense technology market, spanning AI-driven battlefield intelligence, drone services, and public safety applications.

Dan Erdberg, Safe Pro Group’s Chairman and CEO emphasized that the Russell Microcap(R) Index membership will support Safe Pro’s mission of advancing security technologies. “As AI and drone technologies rapidly transform the defense, security, and humanitarian sectors, our proprietary solutions are positioned to play a critical role,” he noted. “Being added to the Russell Microcap(R) Index marks a key milestone in expanding our reach with investors and highlights the broader relevance of our mission and technology. The inclusion into the FTSE Russell underscores our ongoing momentum and strategic growth.”

For more information, visit the company’s website at www.SafeProGroup.com.

• The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE Therapeutics, is expected to be immediately accretive to revenue and EBITDA.
• Cohen, serving the Sarasota-Bradenton area in Florida, specializes in treatments, including ketamine and TMS, for mood disorders, PTSD, and suicidal depression.
• HOPE Therapeutics is expanding toward a target of 30 clinics with a $100 million run rate by the end of 2025.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly-owned subsidiary HOPE Therapeutics, Inc., a multi-site clinical care delivery organization, recently signed a binding letter of intent to acquire a 49% stake in Cohen and Associates, LLC, a respected neuropsychiatry clinic based in western Florida (https://ibn.fm/geIxF).

The agreement, announced on June 26, positions Cohen as a foundational clinic in the Sarasota-Bradenton region for HOPE’s growing network. Cohen and Associates, led by Dr. Rebecca Cohen, offers a comprehensive range of psychiatric care options, including ketamine infusions, Spravato, transcranial magnetic stimulation (“TMS”), and medication management for conditions such as suicidal depression and PTSD.

Founded in 2014, Cohen has established a reputation for delivering thorough psychiatric evaluations and interventional care. Dr. Cohen, an interventional psychiatrist and psychopharmacologist, is known nationally for her expertise in TMS. Her academic achievements include recognition from Tufts University, Boston University, and Georgetown University, and she has been honored as a Fellow of both the American Psychiatric Association and the International Clinical TMS Society.

“I am thrilled to be working with HOPE at this exciting juncture in the company’s evolution,” Dr. Cohen said. “Our goal will always be to deliver outstanding patient care by offering the best available treatments and individualized care.”

HOPE Therapeutics is building a network of interventional psychiatry clinics that combine advanced treatments such as TMS and ketamine with a digital therapeutic-enabled platform to improve outcomes. The company is targeting up to 30 clinics and a $100 million pro forma run rate by the end of 2025.

HOPE’s co-CEOs, Jonathan Javitt and Matthew Duffy, expressed confidence that the Cohen acquisition will support their mission of expanding evidence-based, compassionate care. “We are delighted to welcome Rebecca and her team to the HOPE family. Her extensive experience with neuroplastic therapies, combined with compassionate patient care exemplify our culture of bringing HOPE to life,” they said.

According to the announcement, the transaction is expected to be immediately accretive to both revenue and EBITDA, underlining its strategic fit for HOPE Therapeutics’ clinic-based growth plans. The acquisition is subject to final agreements and standard closing conditions, with further details to be disclosed once definitive transaction documents are signed.

NRx Pharmaceuticals has been active on multiple clinical development fronts, working to advance therapies for mood disorders, PTSD, and acute suicidality through its NMDA-based platform. The company recently filed a new application for a Commissioner’s National Priority Voucher to accelerate review of NRX-100, a preservative-free intravenous ketamine formulation. In parallel, the company has filed an Abbreviated New Drug Application (“ANDA”) for NRX-100 with a request for priority review.

For more information, visit the company’s website at www.NRxPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to NRXP are available in the company’s newsroom at https://ibn.fm/NRXP

• New Pacific Metals owns two of the largest undeveloped open-pit silver projects globally, both located in Bolivia.
• Its flagship Silver Sand project is projected to produce 12 million ounces of silver annually at low all-in sustaining costs.
• The Carangas project could add 6.6 million ounces of silver annually, with over 1 million ounces of gold potential at depth.
• New Pacific is working through Bolivia’s permitting process to unlock the upside potential of its high-quality, large-scale projects.
• Global silver demand, particularly for industrial and renewable energy applications, adds urgency to project development.

New Pacific Metals (NYSE American: NEWP) (TSX: NUAG), a Canadian exploration and development company, is in a unique position to fill a critical and growing supply gap in the global silver market, with two large-scale projects in Bolivia. The company’s progress is focused on advancing these assets through permitting in a country that remains geologically rich.

The company’s two primary projects, Silver Sand and Carangas, are among the best undeveloped open-pit silver assets in the world. A preliminary feasibility study (“PFS”) published in June 2024 highlights the strong potential of the flagship Silver Sand project, which is expected to deliver 12 million ounces of silver annually over a 13-year mine life. The early years are even more productive, with output estimated at 15 million ounces per year, with total projected production reaching 157 million ounces. The project carries a post-tax net present value (“NPV5%”) of US$740 million and a 37% internal rate of return (“IRR”) at a conservative silver price of US$24 per ounce. The all-in sustaining cost is estimated at just US$10.69 per ounce, with a rapid payback period of under two years.

The Carangas Project’s preliminary economic assessment (“PEA”), released in September 2024, outlines a low-cost open-pit mine that targets only the upper silver-lead-zinc zone to produce 6.6 million ounces of silver annually over a 16-year mine life. The economics are also favorable: a post-tax NPV5% of US$501 million, a 26% IRR, AISC of $7.60 per ounce net of lead and zinc by-products, and a 3.2-year payback period at $24 per ounce silver. Notably, Carangas also has more than 1 million ounces of gold potential at depth, not yet incorporated into the PEA.

Together, these projects position New Pacific to potentially produce nearly 19 million ounces of silver per year, placing it in the upper ranks of primary silver producers, once both projects enter production.

Permitting efforts for the two projects are well underway, though the process requires time and patience. Still, it highlights a major opportunity: Bolivia is starved of foreign investment needed to revitalize its mining sector—offering significant upside for early movers.

New Pacific is backed by strong players in the precious metals market. The company is 28% owned by Silvercorp Metals (NYSE-A: SVM) (TSX: SVM), a Canadian mining company producing silver with a long history of profitability, and 13% owned by Pan American Silver (NYSE: PAAS) (TSX: PAAS), which bills itself as the world’s premier silver producer. Both shareholders view the Bolivian projects as serious long-term strategic opportunities that could also attract buyers or partners once development milestones are reached.

Global demand for silver is rising—not just from investors, but from industrial and renewable energy sectors, including photovoltaic solar panels and electric vehicles. According to the World Silver Survey, industrial applications now account for an astonishing 83% of annual silver demand (https://ibn.fm/pniUI).

With few large-scale silver projects under development worldwide, New Pacific’s pipeline is notable. As many silver producers pivot to gold or base metals simply because of a lack of primary silver resources, New Pacific offers pure silver leverage—a rare commodity in today’s market.

For more information, visit the company’s website at www.newpacificmetals.com/welcome.

NOTE TO INVESTORS: The latest news and updates relating to NEWP are available in the company’s newsroom at https://ibn.fm/NEWP 

• The FDA offered supportive feedback on Clene’s proposed statistical analysis plan during a recent Type C meeting.
• The neurofilament biomarker analysis results could support an accelerated approval submission for CNM-Au8 later in 2025.
• Clene has two additional FDA meetings scheduled in Q3 2025 to discuss ALS survival data and its MS program.
• Nearly 200 ALS patients are participating in the NIH-sponsored Expanded Access Program for CNM-Au8.
• The analysis aims to validate the neuroprotective effects shown in previous HEALEY Platform Trial results.

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), is set to move ahead with neurofilament biomarker analyses for its lead candidate CNM-Au8(R) ALS early in the fourth quarter of 2025. The announcement follows a recent productive Type C meeting with the U.S. Food and Drug Administration (“FDA”) (https://ibn.fm/F5AHk). 

The planned analyses will examine changes in neurofilament light chain (“NfL”), a recognized biomarker for neurodegeneration, among nearly 200 ALS patients treated through the National Institutes of Health–sponsored Expanded Access Program (“EAP”) for CNM-Au8. The company’s statistical plan will compare these patients to matched ALS controls, with a primary analysis at nine months and a supportive analysis at six months of treatment.

In the Expanded Access Program, CNM-Au8 is being administered on a compassionate use basis to people living with ALS. The company will analyze whether reductions in NfL from this cohort mirror or exceed the neuroprotective trends reported in the double-blind HEALEY trial.

Benjamin Greenberg, MD, Head of Medical at Clene, described the FDA’s feedback as “constructive” and said the agency’s acceptance of Clene’s revised statistical plan is expected this summer. Clene has already resubmitted its updated analysis plan to the FDA to incorporate requested changes, aiming to finalize the evaluation framework ahead of its fourth-quarter biomarker review.

“We are encouraged by the FDA’s collaborative approach and their constructive feedback on our NfL biomarker analysis plan from the ongoing NIH-sponsored EAP program,” said Greenberg. “With two additional FDA meetings scheduled to discuss long-term ALS survival results and the End-of-Phase 2 MS results, we are advancing our ALS and MS programs to deliver an innovative therapy for people living with neurodegenerative diseases.”

A positive outcome from this NfL assessment is likely to strengthen Clene’s case for a new drug application (“NDA”) submission under the accelerated approval pathway before the end of 2025. The company is seeking to build on data from the HEALEY ALS Platform Trial, where CNM-Au8 showed encouraging neuroprotective signals over a six-month period.

Alongside the biomarker study, Clene confirmed two additional FDA meetings are scheduled for the third quarter of 2025. The first will review survival data from patients receiving 30 mg CNM-Au8 compared with controls from another arm of the HEALEY Platform Trial. The second meeting will focus on the company’s multiple sclerosis program, discussing Phase 2 data from the VISIONARY-MS trial and Clene’s plans for a Phase 3 study targeting cognitive outcomes.

The FDA’s engagement on multiple fronts highlights a potentially promising path forward for CNM-Au8, an oral suspension of gold nanocrystals designed to improve cellular energy production and utilization, which is critical for maintaining neuronal health. Clene hopes these data will support broader approval opportunities for ALS, where treatment options remain limited.

In addition to its ALS program, Clene is keeping momentum in its multiple sclerosis research, using similar bioenergetic principles focused on mitochondria within the central nervous system to develop therapies that could improve cognitive outcomes for people living with MS. The company expects its end-of-Phase 2 MS discussion with the FDA in the third quarter will set the stage for a larger Phase 3 trial.

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

• Lahontan has commenced column leach testing at Santa Fe, targeting more efficient cyanide leach gold recovery in the mixed oxide-sulfide transition zone
• The Santa Fe project serves as the backbone of Lahontan’s development strategy
• Beyond metallurgical testing, Lahontan is preparing for an expanded 2025 drilling campaign to resource growth and project optimization

Lahontan (TSX.V: LG) (OTCQB: LGCXF) is accelerating its mission to develop top-tier gold and silver assets in Nevada’s renowned Walker Lane, with a renewed focus on advancing the Santa Fe project toward production. In its latest strategic move to accomplish that mission, the company has initiated in-depth metallurgical testing aimed at significantly enhancing gold and silver recoveries from the transition zone of its flagship deposit (ibn.fm/N6bTh).

In June, Lahontan announced that it has commenced column leach testing at Santa Fe, targeting more efficient cyanide leach gold recovery in the mixed oxide-sulfide transition zone. During the project’s Preliminary Economic Assessment (“PEA”), this domain achieved only 49% gold recovery, a figure Lahontan aims to improve upon. Results are anticipated later this year, with the company also refining metallurgical domain boundaries across the deposit. 

“We are excited to begin this new program of metallurgical testing on the Santa Fe deposit,” said CEO and executive chair Kimberly Ann. “A significant portion of the minable gold ounces at Santa Fe lie in the transition metallurgical domain, therefore improved gold and silver recoveries will have an immediate and important impact on project economics. 

“New heap leaching methods, including reagents, have shown dramatic increases in recoveries from transition material,” she continued. “We intend to find out if these new processing methods can work at Santa Fe. In addition, once assay results are received from the recent drilling at Slab, we will begin additional test work on the bulk rejects, looking for ways to optimize gold and silver recoveries at Slab as well.”

The Santa Fe project serves as the backbone of Lahontan’s development strategy. Historically, the site produced approximately 359,000 ounces of gold and 702,000-plus ounces of silver between 1988 and 1995 using open-pit heap leach methods. Under current management, the resource has been independently estimated at more than 1.5 million ounces gold equivalent in the indicated category (48.4 million tonnes grading 0.92 g/t Au and 7.18 g/t Ag) and 411,000 ounces gold equivalent in the inferred category (16.8 million tonnes grading 0.74 g/t Au and 3.25 g/t Ag), all within a pit-constrained model. Improving recoveries in the transition zone, where substantial resources remain, could significantly enhance project economics and production forecasting.

Beyond metallurgical testing, Lahontan is preparing for an expanded 2025 drilling campaign to resource growth and project optimization. The company recently announced that the Bureau of Land Management (“BLM”) approved an amendment to its Notice of Intent, unlocking access to additional high-priority drill sites at Slab and York, key areas for discovering extensions of existing mineralization (ibn.fm/KLznm). The forthcoming program will continue phase one drilling, with assays expecting to be a vital step in expanding the existing resource and updating the Santa Fe PEA.

Historically, Lahontan has demonstrated strong metallurgical potential at Santa Fe. A January 2024 review led by Kappes Cassiday and Associates reported weighted heap leach recoveries of 74.4% for gold and 29% for silver in oxide zones (ibn.fm/vjJ4O). Complementary shake analyses released in September 2024 found CN-soluble gold levels reaching as high as 91.5% in deposits such as Calvada and York, reinforcing confidence in high recoveries for the oxide domain and providing a solid baseline for the transition zone work (ibn.fm/rAZI9).  

The planned improvements are deeply integrated into Lahontan’s broader business objectives. The company aims to update its PEA with new metallurgical data and results from ongoing drilling. In May 2024, Lahontan engaged KCA, RESPEC and Equity Exploration to advance its PEA, encompassing flow-sheet design, mine infrastructure, and block model enhancements (ibn.fm/oS8a9). These milestones support Lahontan’s goal of repositioning Santa Fe as a near-term producer within the Walker Lane, while also evaluating satellite properties such as West Santa Fe, Moho and Redlich for future exploration and development.

Santa Fe’s historical pedigree, coupled with Lahontan’s modern technical groundwork, positions the project favorably in a highly productive and mining-friendly jurisdiction. Walker Lane has produced more than 40 million ounces of gold previously and offers multiple deposit types — epithermal, porphyry and skarn — across its 500-mile trend (ibn.fm/MTPhJ). Lahontan’s four-property portfolio spans Santa Fe, West Santa Fe, Moho and Redlich, offering a diversified outlook within this emerging mining region .

Lahontan Gold’s initiation of transition zone metallurgical testing at Santa Fe marks a pivotal step toward unlocking untapped value within its resource base. With anticipated results by year-end and additional drilling underway, the company is steadily advancing production readiness. As it enhances recoveries, updates its PEA and progresses toward project execution, Lahontan continues to reinforce its vision of becoming a leading gold and silver producer in Nevada’s Walker Lane region.

For more information, visit the company’s website at www.LahontanGoldCorp.com. 

NOTE TO INVESTORS: The latest news and updates relating to LGCXF are available in the company’s newsroom at ibn.fm/LGCXF

• BlueSky AI has positioned itself at the forefront of the booming AI infrastructure market through the introduction of its flagship SkyMod modular data centers
• BSAI’s vision is to empower the AI ecosystem, enabling companies to focus on innovation while they provide the critical infrastructure needed to succeed
• By focusing on universal computing needs rather than tying itself to single AI applications, BlueSky offers an investment proposition rooted in scale and resilience

BlueSky AI (OTC: BSAI) has rapidly emerged as a key player in modular AI data center infrastructure, achieving major milestones in the past two years. The company has moved from concept to execution with its scalable SkyMod solutions, stepped up its market visibility by upgrading to the OTCID tier, and partnered with industry accelerators, marking significant progress toward becoming an essential AI player in the data center space.

BlueSky AI has positioned itself at the forefront of the booming AI infrastructure market through the introduction of its flagship SkyMod modular data centers (ibn.fm/JyaTa). Designed for rapid deployment, these prefabricated units — SkyMod One (1 MW) and SkyMod XL (1.7 MW) — address the urgent need for scalable, energy-efficient AI compute power, while integrating advanced cooling and renewable energy compatibility (ibn.fm/7oQXq).

“Artificial intelligence is fueling an extraordinary surge in compute power demands,” said BlueSky AI CEO Trent D’Ambrosio. “BluSky AI is meeting the AI compute challenges with modular, scalable, an accelerated time to market, and energy-efficient data center solutions. Our vision is to empower the AI ecosystem, enabling companies to focus on innovation while we provide the critical infrastructure they need to succeed.” D’Ambrosio emphasizes that BlueSky’s infrastructure-first model eliminates the uncertainty of investing in specific AI companies, instead offering computing capacity that underpins all AI development.

The global data center market is currently valued at an estimated $347.6 billion in 2024 (ibn.fm/J0LEb). Projections forecast industry growth at 11.2% CAGR, reaching $652 billion by 2030, creating an impressive opportunity and indicating that BlueSky’s modular approach aligns perfectly with investor and industry demand.

In addition, last month BlueSky announced a transition from the OTC Pink tier to the OTCID tier effective July 1, 2025, signaling growing financial maturity and compliance readiness (ibn.fm/ZSmAd). This upgrade follows other strategic moves including a GPU-as-a-Service launch, new infrastructure partnerships and improved financial governance. BlueSky’s engagement with IBN to lead corporate communications underscores its focus on transparency and investor relations, positioning the company for wider capital market access (ibn.fm/Ym96W).

BlueSky AI’s mission is to empower AI innovators by eliminating infrastructure bottlenecks and accelerating time-to-compute with energy-efficient, scalable solutions. By focusing on universal computing needs rather than tying itself to single AI applications, BlueSky offers an investment proposition rooted in scale and resilience. Its off-site tested and fully assembled SkyMod units are optimized for plug-and-play deployment on BlueSky-owned land or at client sites, supporting rapid expansion and simplified logistics. Built with support for renewable energy and advanced cooling, these systems are engineered for sustainability, a key differentiator in a carbon-conscious digital age.

Leadership at BlueSky AI reflects deep domain expertise. D’Ambrosio brings a diverse background in telecommunications, finance and infrastructure. CTO Julien Bedard has extensive experience in cloud systems and cybersecurity, and COO Dan Gay adds operational excellence from decades in telecom and technology deployment. This team is committed to scaling globally within North America, where demand accounts for more than 40% of the global data center market and is expected to grow at a 10.7% CAGR from 2025 to 2030.

As BlueSky transitions to the OTCID tier, its high-profile capitalization moves, and heightened visibility further reinforce its market credibility. Daily stock traction continues to grow, supported by enhanced communications strategies and deepening investor engagement.

Looking ahead, BlueSky AI is focused on expanding SkyMod deployments, finalizing key infrastructure partnerships and scaling modular data centers across AI innovation hubs. Its first strategy offers a robust framework for investors looking to participate in the AI expansion without the risk tied to individual application performance. By combining rapid deployment technology, sustainability-minded infrastructure, regulatory compliance and roadmap-based execution, BlueSky AI is establishing itself as a foundational enabler of the next-generation AI ecosystem.

For more information, visit the company’s website at BluSkyAIDataCenters.com.

NOTE TO INVESTORS: The latest news and updates relating to BSAI are available in the company’s newsroom at https://ibn.fm/BSAI

• Nutriband and Kindeva have completed commercial-scale manufacturing for AVERSA(TM) Fentanyl, a major milestone in the path to FDA approval
• Updated analyst report raises NTRB’s price target to $15.00 and reiterates an Outperform rating, citing favorable trial pathway and strong execution
• Aversa abuse-deterrent tech is protected by international patents and may address a global unmet need in safe pain management
• NTRB boosting their profile and credibility with its recent membership to the Russel Indexes

The opioid crisis remains one of the most pressing public health challenges of our time. While synthetic opioids like fentanyl play a crucial role in managing severe pain, their high abuse potential has led to a growing demand for smarter, safer delivery systems. As policymakers, healthcare providers, and regulators seek solutions that balance medical necessity with public safety, innovative technologies are emerging that could reshape how these powerful drugs are administered.

Nutriband and Kindeva Reach Key Manufacturing Milestone

One company aiming to bridge this gap is Nutriband (NASDAQ: NTRB). Recently, Nutriband announced it has completed commercial manufacturing process scale-up for its lead product, AVERSA(TM) Fentanyl, in partnership with global contract manufacturer Kindeva Drug Delivery. The achievement represents a critical step toward launching the world’s first abuse-deterrent transdermal fentanyl patch.

Aversa combines Nutriband’s proprietary abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch platform, and it is manufactured at Kindeva’s U.S.-based transdermal facility. With this milestone met, the company is now preparing to produce clinical supplies and submit an Investigational New Drug (“IND”) application to the FDA.

Unlike many traditional drug development pipelines, Aversa Fentanyl is positioned to follow the streamlined 505(b)(2) regulatory pathway, requiring only a single Phase 1 human abuse liability study prior to New Drug Application (“NDA”) submission. According to Noble Capital Markets, this study is low risk and designed to show that the Aversa patch is less attractive to potential abusers.

Analyst Coverage Reflects Confidence in Progress

Reflecting the growing confidence in Nutriband’s commercialization strategy, Noble Capital Markets has reiterated its Outperform rating on NTRB stock and raised its price target to $15.00, citing the company’s progress and efficient execution. The firm’s June 20, 2025, report notes that its prior projections accounted for a potential capital raise earlier in the year, which was ultimately not required, further improving earnings per share projections for FY2027.

The report highlights that AVERSA’s NDA is expected in late 2025 or early 2026, with full-year sales forecasted to begin in 2027. Notably, AVERSA Fentanyl is projected to reach peak U.S. annual sales of $80 to $200 million, depending on market penetration and adoption rates.

Intellectual Property and Global Potential

What makes Aversa especially noteworthy is its broad international patent portfolio, with protections granted in 46 countries, including the U.S., Europe, Japan, China, Canada, and Australia. The technology incorporates aversive agents into transdermal patches to deter abuse, misuse, and accidental exposure, common concerns in both hospital and home settings.

Although Nutriband is initially focused on U.S. approval and market entry, the company has clearly signaled its global ambitions, citing widespread unmet need for safer opioid delivery systems. The transdermal market offers a particularly compelling opportunity due to the ease of use and steady drug release profile of patch-based medications.

Kindeva Collaboration Offers Strategic Manufacturing Edge

Nutriband’s manufacturing partner, Kindeva, brings additional validation to the program. A leading CDMO with global reach, Kindeva offers advanced drug-device manufacturing capabilities, including aseptic fill-finish and sustainable inhalation propellants. By pairing Nutriband’s innovation with Kindeva’s manufacturing muscle, the partnership significantly reduces scale-up risk, a hurdle that has hampered many biopharma startups.

This strategic collaboration not only supports Aversa’s path to market but also sets the stage for future pipeline candidates utilizing the AVERSA platform across other transdermal opioids or CNS drugs.

A Timely Innovation for a Market in Need

As regulatory scrutiny on opioid safety continues to mount, Nutriband’s AVERSA(TM) Fentanyl is emerging as a potential game-changer in both pain management and public health. Its abuse-deterrent properties address core safety concerns without sacrificing therapeutic efficacy, a delicate balance that regulators and prescribers are actively seeking.

With clinical testing expected to begin soon and a regulatory path that’s both clear and efficient, Nutriband is well-positioned to transition from development-stage to commercial-stage in the next 18–24 months.

For Boosting their Investment Strategies

Nutriband was recently awarded with membership to the Russell Microcap, Russell Microcap Growth, Russell 3000E and Russell 3000E Growth Indexes, as part of the 2025 Russell indexes reconstitution. Investment managers and investors commonly use Russell indexes to construct index funds and as benchmarks for evaluating active investment strategies. Gareth Sheridan, CEO of Nutriband Inc. explained, “Being added to the four Russell indexes is a great honor for us as a company as we continue to strive towards building shareholder value and progressing the development of our AVERSA pipeline and in particular AVERSA Fentanyl which has the potential to reach peak annual US sales of $80 million to $200 million. We believe our addition now reflects a market focus on us as a company and the momentum we are building to revolutionize the safety profile of easily abused medications while making these medications available to those in need as a result,”

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

• ESGold is celebrating the successful close of a private placement funding effort that will generate important financing for the company’s planned launch of a mine tailings cleanup and reclamation project later this year
• The financing drive was oversubscribed by more than 11%, which ESGold executives hail as evidence that investors like the company’s strategy for generating revenue 
• The company holds 265 mining claims on the historic Montauban mine site in Quebec, covering 13,116 hectares (about 32,410 acres) of gold and silver exploration
• ESGold expects to begin mill circuit production on the tailings cleanup later this year
• Mica recovered in the reclamation would be used in an innovative concentrate that is stronger than concrete and usable for construction materials such as bricks, parking columns, and highway Jersey barriers

ESGold (CSE: ESAU) (OTCQB: ESAUF), a pre-production gold and silver resource developer operating in Canada, has closed its recent non-brokered private placement funding effort after seeing a successful raise of $3,649,171 in aggregate gross proceeds to assist its pending processing of a site’s abandoned tailings. 

“This Offering was over-subscribed by more than 11% as a direct result of large investments by existing shareholders and new strategic investors who recognized that ESGold is focused and on track to production in the very near future,” ESGold CEO and Director Paul Mastantuono stated in a June 25 news release on the situation (https://ibn.fm/a3phQ).

ESGold is preparing to begin production later this year on a toxic tailings cleanup operation that will extract mica as well as any remaining gold and silver at the company’s mining claims on the historic Montauban mine site in Quebec, 80 kilometers (49.7 miles) west of the province’s capital city. The tailings cleanup effort is expected to generate significant asset value for shareholders through revenues derived from the cleanup operation, particularly by way of selling a concentrate that will be useful in building materials such as bricks, cinder blocks, paving stones, patio tiles, parking columns, and highway Jersey barriers.

ESGold has partnered with private consultancy DMCMS Inc., whose clean technology fuses mine waste with an organic polymer to create the concentrate, which is stronger than concrete. The cleanup will also allow ESGold to shine as the company fulfills its corporate sustainability goal of restoring mine sites back to a natural “green” state.

Production is expected to begin by year-end, and the private placement raise will be used for the construction of the mill circuit and related assembly, as well as needs for final mobilization of the project and general working capital requirements, according to the company. 

As revenues are generated by the gold, silver, and mica recovered from the tailings cleanup, the company will begin working to reinvest it in new district scale exploration potential at the Montauban mine site. 

The company’s strategic plan has proved popular with existing investors, including key stakeholders as well as New York-based hedge funds and family offices. “Their ongoing participation highlights the growing institutional confidence in ESGold’s clean production model and its near-term exploration potential,” a June 23 news release adds (https://ibn.fm/7f9Fr).

“We have the capacity to generate on our first four, five years, close to $350 million on this low-hanging fruit (the tailings mineral cleanup and reuse), with almost zero (additional) cost,” Mastantuono said during an interview with the Exploring Mining Podcast that highlighted the company’s excitement for its successful ramp-up thus far (https://ibn.fm/a5sUH).

For more information, visit the company’s website at https://esgold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• The company announced its expansion into the $395 billion global data center market as a developer, owner, and strategic partner.
• The move underscores SolarBank’s commitment to integrating renewable energy in diverse, emerging sectors.
• AI data centers are projected to need 30 times more power by 2035, creating a critical opportunity for clean energy solutions.
• The company joins tech giants and specialized data center providers focused on sustainability and resilience in digital infrastructure.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., continues its focus on  the rapidly growing data center sector, highlighting its plan to serve as a developer, owner, and partner in one of the world’s fastest-expanding infrastructure markets. This focus comes as the global data center industry is forecast to reach $395 billion by 2030, fueled by explosive demand for cloud computing, big data, and artificial intelligence technologies (https://ibn.fm/8SI6a).

SolarBank’s focus arrives at a pivotal time for the sector. According to Deloitte, the power consumption of AI data centers could jump from 4 gigawatts today to 123 gigawatts by 2035, a thirtyfold increase that will stretch existing power grids and infrastructure (https://ibn.fm/bFoCC). The scale of that growth underscores a crucial challenge: meeting enormous power demands while maintaining environmental responsibility.

Richard Lu, CEO of SolarBank, described the expansion as a natural progression of the company’s mission (https://ibn.fm/ohBpQ). “Our experience in renewable energy will enable us to deliver energy-efficient, carbon-reducing data centers to support today’s data needs and tomorrow’s technological advancements,” Lu said.

The stakes are high. Deloitte warns that while data centers can be built relatively quickly, delays in power infrastructure, including long lead times for new gas plants and seven-year waits for grid connections, risk bottlenecking AI growth. Simultaneously, the data center sector faces skilled labor shortages, supply chain challenges, and increasingly strict environmental regulations, complicating timelines for construction and permitting.

Amid these headwinds, SolarBank is positioning its renewable energy expertise as a potential solution. The company intends to build partnerships in energy-efficient, low-carbon data center infrastructure, addressing the industry’s carbon footprint and helping data centers meet their sustainability targets. SolarBank’s move parallels efforts by Amazon, Google, and Microsoft, which have poured billions into ensuring their data centers align with climate goals.

In fact, large tech companies and specialized data center operators, from Meta Platforms to Equinix and Digital Realty, have collectively invested over $100 billion in new facilities over the past five years. Like SolarBank, these firms see sustainability as a critical differentiator as they navigate rising power demands and public pressure to decarbonize.

SolarBank is expanding into the data center industry, but does not currently have any data center projects under development nor any for which it has secured rights. SolarBank does not have any contracts with the parties mentioned in this report. It is in discussions with various other parties regarding potential data center opportunities and will provide details in a future news release if an agreement to acquire or develop a data center is concluded.

As SolarBank broadens its reach, it is exploring strategic partnerships with existing data center developers and infrastructure specialists. The company aims to create solutions that are scalable, resilient, and future-focused, offering not only power capacity but also lower carbon intensity in an industry often criticized for its heavy energy consumption.

As Lu noted, “Expanding into the data center business aligns with our vision of creating a resilient and sustainable energy grid.” That vision appears increasingly relevant as the global economy grows more dependent on digital infrastructure and the electricity to power it.

SolarBank’s foray into data centers underscores its commitment to integrating renewables across emerging and diverse markets, tapping into a powerful trend of decarbonization in mission-critical infrastructure. “As the world accelerates toward a future driven by AI, automation, and clean energy, SolarBank remains committed to delivering innovative, scalable solutions that not only power industries but also empower communities,” Lu concluded.

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward looking information. Please refer to the press release entitled “SolarBank Expands into the projected $395 Billion Data Center Market as Developer and Strategic Partner” for additional details.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN